Evidence map›Paper›PMID 22740822›Full record

ArticleCase reports in oncology2012

Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literature.

Marinos Pericleous, Christos Toumpanakis, Heather Lumgair, Martyn E Caplin, Luke Morgan-Rowe, Ian Clark, Tu Vinh Luong

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Gastric mixed adenoneuroendocrine carcinoma case report.SAGE open medical case reports · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in the diagnosis and treatment of gastric neuroendocrine neoplasms.Translational gastroenterology and hepatology · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marinos PericleousDepartment of Neuroendocrine Tumours, European Center of Excellence, Royal Free Hospital, London, UK.
Christos Toumpanakis
Heather Lumgair
Martyn E Caplin
Luke Morgan-Rowe
Ian Clark
Tu Vinh Luong

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most gastric neuroendocrine tumours are well differentiated and considered as neuroendocrine neoplasms, whilst poorly differentiated lesions are considered as neuroendocrine carcinomas and account for only 6-16% of gastric neuroendocrine tumours. Gastric mixed adenoneuroendocrine carcinomas are rare malignancies usually composed of a neuroendocrine carcinoma and an adenocarcinoma with a variable grade of differentiation. Here, we report an unusual and rare gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation including a neuroendocrine carcinoma, an adenocarcinoma and a squamous cell carcinoma. A brief discussion of the histopathological features, biological behaviour and treatment of this rare tumour type is presented.

Indexed as

Gastric neuroendocrine tumoursMANECTrilineage differentiation

Identifiers

PMID22740822
PMCPMC3383252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.